Sebastian A. Meier-Ewert
Directeur Général chez Prosalix GmbH
Profil
Sebastian A.
Meier-Ewert was the founder of GPC Biotech AG (1997) where he held the title of Chief Scientific Officer & Senior Vice President until 2009, and iOmx Therapeutics AG (2016) where he held the title of Chief Executive Officer.
Dr. Meier-Ewert's current job is as Chief Operating Officer at GPC Biotech, Inc. (since 1997).
Dr. Meier-Ewert's former jobs include Director-Supervisory Board at Immatics Biotechnologies GmbH, Managing Director at SAW Instruments GmbH, and Managing Director at KI Kapital GmbH.
Dr. Meier-Ewert received a doctorate from the University of London and an undergraduate degree from University College London.
Dr. Meier-Ewert is also the founder of Prosalix GmbH.
Postes actifs de Sebastian A. Meier-Ewert
| Sociétés | Poste | Début |
|---|---|---|
GPC Biotech, Inc.
 GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Directeur des opérations | 01/01/1997 |
| Prosalix GmbH | Directeur Général | 19/05/2011 |
Anciens postes connus de Sebastian A. Meier-Ewert
| Sociétés | Poste | Fin |
|---|---|---|
GPC Biotech AG
 GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Fondateur | 02/12/2009 |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Directeur Général | - |
KI Kapital GmbH
 KI Kapital GmbH Investment ManagersFinance KI Kapital operates as a entrepreneurial consulting and private equity company. It support companies during growth phases both through consulting regarding strategic and operational challenges as well as through investments. The company was founded in 2009 and is base in Muchen, Germany. | Directeur Général | - |
SAW Instruments GmbH
 SAW Instruments GmbH Medical SpecialtiesHealth Technology SAW Instruments GmbH designs, develops and sells biosensor-based laboratory instruments. Its products are used to measure proteins in cells, membranes and liposome's using an amplitude parameter to detect conformational changes. The firm carries out the orthodox functions of affinity measurements, kinetics and concentration determination. The company was founded by Sabine Bois and Markus Perpeet in 2010 and is headquartered in Munich, Germany. | Directeur Général | - |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Directeur/Membre du Conseil | - |
Formation de Sebastian A. Meier-Ewert
| University of London | Doctorate Degree |
| University College London | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
GPC Biotech AG
GPC Biotech AG Miscellaneous Commercial ServicesCommercial Services GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.It is headquartered in Martinsried/Munich (Germany). The Company's wholly owned U.S. subsidiary has research and development sites in Waltham, Massachusetts and Princeton, New Jersey | Commercial Services |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
SAW Instruments GmbH
SAW Instruments GmbH Medical SpecialtiesHealth Technology SAW Instruments GmbH designs, develops and sells biosensor-based laboratory instruments. Its products are used to measure proteins in cells, membranes and liposome's using an amplitude parameter to detect conformational changes. The firm carries out the orthodox functions of affinity measurements, kinetics and concentration determination. The company was founded by Sabine Bois and Markus Perpeet in 2010 and is headquartered in Munich, Germany. | Health Technology |
KI Kapital GmbH
KI Kapital GmbH Investment ManagersFinance KI Kapital operates as a entrepreneurial consulting and private equity company. It support companies during growth phases both through consulting regarding strategic and operational challenges as well as through investments. The company was founded in 2009 and is base in Muchen, Germany. | Finance |
| Prosalix GmbH | |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |